Hypoglycaemia: Intramuscular and intravenous glucagon were similar in effect
|
|
|
Clinical bottom line (level 2b-)
-
In patients with hypoglycaemic coma, intramuscular and intravenous glucagon appeared similar in their ability to rouse.
|
|
MacCuish et al:
Lancet
1970;
1:
946-949
|
Expires
August 2003
|
The study
Single-blinded ?concealed quasi-randomised
trial
with
intention-to-treat
Setting: diabetic or accident and emergency department of one hospital, UK
100 patients
(aged
range 20 to 40 years,
?%
male)
diabetics brought by ambulance or car at the request of a doctor, relative, friend or police, with suspected hypoglycaemia
Control Group: (n = 50, 50 analysed):
intravenous
glucagon
1mg
Experimental Group: (n = 50, 50 analysed):
intramuscular
glucagon
100% followed for
60
minutes
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| recovery in <0 mins
|
30
minutes |
32 (64%) |
27 (54%) |
16% (-17% to
39%) |
10% (-9% to
29%) |
10
(NNT = 3 to infinity;
NNH =
11
to infinity)
|
Comments
- No details of randomisation given; from exact 50/50 split and the decision to enter 100 patients it may be reasonable to assume it's alternate allocation
- 'Recovery' included ability to take oral glucose; may vary from other definitions
Citation
-
MacCuish
AC,
Munro
JF,
Duncan
LJP:
Treatment of hypoglycaemic coma with glucagon, intravenous dextrose, and mannitol infusion in a hundred diabetics.
Lancet
1970;
1:
946-949
Contributor: Bob Phillips and Clare Wotton,
August 1999
Reviewer:
Clinical Question.
| Patient |
in patients with hypoglycaemia and altered mental status |
| Intervention or Exposure |
intravenous glucagon |
| Comparison |
intramuscular glucagon |
| Outcome |
speed of recovery or requirement for further treatment |
|
|